B-cell deficiency ameliorates the progression of NASH through MyD88 signaling. FMT from NAFLD patients promotes the pathogenesis of NASH mice by increasing the activation and accumulation of intrahepatic B cells [251]. Here, MYD88 is linked to metabolic dysfunction-associated steatotic liver disease.